On November 15, 2021, CloudMD Software & Services Inc. and MindBeacon Holdings Inc. announced that they had entered into a definitive arrangement agreement under which CloudMD will acquire all of MindBeacon’s issued and outstanding common shares for a combination of cash and shares valued at approximately $116 million. Under the terms of the agreement, each common share of MindBeacon will be exchanged for $1.22 of cash and 2.285 common shares of CloudMD.
CloudMD’s mental health platform, addressing all points of a patient’s healthcare journey, paired with MindBeacon’s clinically-proven iCBT will be one of North America’s leading fully-integrated health offerings, with a clinically-validated, broad continuum of care to address mild, moderate, acute and chronic mental and physical care.
Cassels is acting for CloudMD.